Literature DB >> 23143554

Clinically silent Crohn's disease in a patient with Takayasu's arteritis unresponsive to conventional therapies.

Neslihan Yilmaz1, Meryem Can, Fatma Alibaz-Oner, Haner Direskeneli.   

Abstract

Takayasu arteritis (TA) and Crohn's disease (CD) are chronic inflammatory diseases with granulomatous nature. Here, we report a case of TA with a silent course of CD who was refractory to corticosteroid and immunosuppressive treatments and improved with adalimumab therapy.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23143554     DOI： 10.1007/s00296-012-2558-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  13 in total

1.  The epidemiology of Crohn's disease.

Authors:  C N Bernstein; J F Blanchard
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

Review 2.  Association of Takayasu's arteritis and Crohn's disease. Results of a study on 44 Takayasu patients and review of the literature.

Authors:  Jean-Luc Reny; Jean-François Paul; Chantal Lefèbvre; Karine Champion; Joseph Emmerich; Olivier Blétry; Jean-Charles Piette; Jean-Noël Fiessinger
Journal:  Ann Med Interne (Paris)       Date:  2003-03

3.  Adalimumab for the treatment of inflammatory bowel disease.

Authors:  Sharmeel K Wasan; Sunanda V Kane
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2011-12       Impact factor: 3.869

4.  Crohn's disease of the colon with takayasu's arteritis.

Authors:  S J Lenhoff; A S Mee
Journal:  Postgrad Med J       Date:  1982-06       Impact factor: 2.401

5.  Takayasu's arteritis progression on anti-TNF biologics: a case series.

Authors:  Mohammed Osman; Stephen Aaron; Michelle Noga; Elaine Yacyshyn
Journal:  Clin Rheumatol       Date:  2011-01-11       Impact factor: 2.980

6.  Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.

Authors:  W J Sandborn; S B Hanauer; S Katz; M Safdi; D G Wolf; R D Baerg; W J Tremaine; T Johnson; N N Diehl; A R Zinsmeister
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

7.  Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.

Authors:  E S Molloy; C A Langford; T M Clark; C E Gota; G S Hoffman
Journal:  Ann Rheum Dis       Date:  2008-08-03       Impact factor: 19.103

8.  Takayasu's arteritis following Crohn's disease in a young woman: any evidence for a common pathogenesis?

Authors:  Melissa- A L Farrant; Justin C Mason; Newton A C S Wong; Robert J Longman
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

Review 9.  Takayasu's arteritis in a patient with Crohn's disease: an unexpected association during infliximab therapy.

Authors:  Nagaaki Katoh; Mayu Kubota; Yasuhiro Shimojima; Wataru Ishii; Masayuki Matsuda; Taiji Akamatsu; Shu-ichi Ikeda
Journal:  Intern Med       Date:  2010-01-15       Impact factor: 1.271

10.  Infliximab to treat Crohn's disease: an update.

Authors:  M Cottone; V Criscuoli
Journal:  Clin Exp Gastroenterol       Date:  2011-09-26
View more
  2 in total

Review 1.  Silent Inflammatory Bowel Disease.

Authors:  Matthew D Coates; David G Binion
Journal:  Crohns Colitis 360       Date:  2021-09-22

2.  Coexistence of Takayasu Arteritis and Crohn's Disease in a Maltese Patient.

Authors:  John Paul Caruana Galizia; Paul John Cassar
Journal:  Case Rep Rheumatol       Date:  2015-12-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.